Exact FDA event identifier

Event 67747

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 03, 2014
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: McKesson Packaging Services

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10

D-1167-2014

Recall number: D-1167-2014
Initiated: March 03, 2014
Classification: Class III
Status: Terminated
Recalling firm: McKesson Packaging Services
Quantity: 1,557 Boxes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Out of Specification

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.

Code information

Lot #: 91357

Distribution pattern

Nationwide